Business
Unverified
Gathered automatically from the outlets below; our newsroom hasn't checked it yet.
Novo Holdings-backed Windward Bio valued at $1 billion as shares rise in Nasdaq debut
Novo Holdings-backed Windward Bio was valued at $1.07 billion after its shares opened above their IPO price in their Nasdaq debut on Friday.